LRCX · 10-K · 2026A · Full report

Capital Expenditures

LAM RESEARCH CORP · 2026-08-07 · Importance 66 · Surprise 74

Capital expenditures increased to $966.4 million in fiscal 2026 from approximately $708.1 million of investing cash use in fiscal 2025. Net cash used in investing activities increased $214.1 million to $922.2 million in fiscal 2026. The increase primarily supported laboratory investments in the United States and global manufacturing-facility growth. Capital expenditures represented a major use of the $5.858 billion of fiscal 2026 operating cash flow.

Key facts

• Increase of $214.1 million in net cash used for investing activities in fiscal year 2026 versus fiscal year 2025 was primarily due to higher capital expenditures to support lab investments in the United States and global growth in manufacturing facilities source
• Net cash used for investing activities in fiscal year 2026: $922.2 million, primarily consisting of capital expenditures; in fiscal year 2025: $708.1 million source
• Capital expenditures amount referenced as $966.4 million in uses of operating cash for fiscal year 2026 source